Processes for making cyclopropyl amide derivatives and intermediates associated therewith

Details for Australian Patent Application No. 2011218491 (hide)

Owner AstraZeneca AB

Inventors Stranne, Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011218491

PCT Pub. Number WO2011/102794

Priority 61/305,583 18.02.10 US

Filing date 17 February 2011

Wipo publication date 25 August 2011

International Classifications

C07C 233/65 Carboxylic acid amides

C07D 241/04 Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 295/182 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

4 October 2012 PCT application entered the National Phase

  PCT publication WO2011/102794 Priority application(s): WO2011/102794

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218492-New crystalline form of a cyclopropyl benzamide derivative

2011218490-Solid forms comprising a cyclopropyl amide derivative